Monte Rosa Therapeutics (NASDAQ:GLUE) PT Lowered to $17.00
Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) had its price target cut by equities researchers at Wells Fargo & Company from $18.00 to $17.00 in a report issued on Monday, Benzinga repo… [+3990 chars]
Monte Rosa Therapeutics (NASDAQ:GLUE) PT Lowered to $17.00
Monte Rosa Therapeutics (NASDAQ:GLUE) PT Lowered to $17.00
Monte Rosa Therapeutics (NASDAQ:GLUE) PT Lowered to $17.00
Monte Rosa Therapeutics (NASDAQ:GLUE) PT Lowered to $17.00
Monte Rosa Therapeutics (NASDAQ:GLUE) PT Lowered to $17.00
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute